| Biomarker ID | 1876 |
| PMID | 30321406 |
| Year | 2019 |
| Biomarker | PD-L2 (Programmed death ligand 2) |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Methylated in PCa |
| Odds Ratio/Hazard Ratio/Relative Risk | HR: 1.17 (95% CI: 1.03 to 1.33) |
| Effect on Pathways | NA |
| Experiment | Biochemical Recurrence Free Survival Vs No Biochemical Recurrence Free Survival |
| Type of Biomarker | Prognostic |
| Cohort | data from formalin-fixed paraffin-embedded samples were obtained from six published retrospective radical prostatectomy cohorts (n=1567). Microarray data are available on the Gene Expression Omnibus with accession numbers GSE46691, GSE62116, GSE72291, GSE62667, GSE79956, GSE79957, and GSE79915. |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p=0.01 |
| Method Used | NA |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | NA |